- J.D., University of Southern California Gould School of Law 2009
- B.A., Psychology, Georgetown University 2006
magna cum laude
Katie Insogna serves as Co-Chair of the Pharmaceutical and Medical Device Product Liability Sub-Practice Group. A four-time honoree by Legal 500 for life sciences and pharmaceutical and medical device defense (2020 as a Rising Star; 2021-2023 as a Next Generation Partner), Katie’s practice focuses on litigation, regulatory, and enforcement challenges facing pharmaceutical, medical device, and life science companies. Her litigation practice primarily involves representing clients in complex, multi-jurisdictional product liability litigation and complex commercial litigation, for which DLA Piper's Product Liability and Mass Tort practice group has been recognized as a leader for years. As part of her Legal 500 recognition, Katie was described as "highly skilled" and "a name to note." Clients recognized that she "excels at handling high-stakes litigation and counselling."
Katie has extensive expertise with fact and expert witness development, discovery and dispositive motion practice, and trial preparation. Katie has taken and defended numerous party and third-party witness depositions in product liability and commercial litigation cases. She also has argued motions in state and federal courts.
In addition to her litigation practice, Katie counsels clients on research and development, risk management, and other compliance issues.
Representative of her experience are the following matters:
During law school, Katie externed for the Honorable Valerie Baker Fairbank, United States District Court for the Central District of California.
Life sciences companies and the risks posed by the mifepristone litigation
19 May 2023 .1 minute read
The Fifth Circuit’s partial stay to the mifepristone order grants partial relief, but...
14 April 2023 .5 minute read
Unsolicited e-mails and information sent to DLA Piper or the independent DLA Piper Relationship firms will not be considered confidential, may be disclosed to others, may not receive a response, and do not create a lawyer-client relationship with DLA Piper or any of the DLA Piper Relationship firms. Please do not include any confidential information in this message. Also, please note that our lawyers do not seek to practice law in any jurisdiction in which they are not properly permitted to do so.